263 results on '"Guo, Xinfeng"'
Search Results
2. Acupuncture and moxibustion for endometriosis: A systematic review and analysis
- Author
-
Wang, Yongxia, Coyle, Meaghan E., Hong, Miaowen, He, Siya, Zhang, Anthony L., Guo, Xinfeng, Lu, Chuanjian, Xue, Charlie C.L., and Liang, Xuefang
- Published
- 2023
- Full Text
- View/download PDF
3. Clinical evidence for acupuncture for adult asthma: Systematic review and meta-analysis of randomised sham/placebo-controlled trials
- Author
-
Pang, Jintao, Shergis, Johannah Linda, Zheng, Lici, Liu, Shaonan, Guo, Xinfeng, Zhang, Anthony Lin, Lin, Lin, Xue, Charlie Changli, and Wu, Lei
- Published
- 2023
- Full Text
- View/download PDF
4. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing
- Author
-
Guo, Xinfeng, Liu, Silvia, Sheng, Yi, Zenati, Mazen, Billiar, Timothy, Herbert, Alan, and Wang, Qingde
- Published
- 2023
- Full Text
- View/download PDF
5. Acupuncture for cancer pain: an evidence-based clinical practice guideline
- Author
-
Ge, Long, Wang, Qi, He, Yihan, Wu, Darong, Zhou, Qi, Xu, Nenggui, Yang, Kehu, Chen, Yaolong, Zhang, Anthony Lin, Hua, Haiqing, Huang, Jinchang, Hui, Ka-Kit, Liang, Fanrong, Wang, Linpeng, Xu, Bin, Yang, Yufei, Zhang, Weimin, Zhao, Baixiao, Zhu, Bing, Guo, Xinfeng, Xue, Charlie Changli, and Zhang, Haibo
- Published
- 2022
- Full Text
- View/download PDF
6. An AGS-associated mutation in ADAR1 catalytic domain results in early-onset and MDA5-dependent encephalopathy with IFN pathway activation in the brain
- Author
-
Guo, Xinfeng, Steinman, Richard A., Sheng, Yi, Cao, Guodong, Wiley, Clayton A., and Wang, Qingde
- Published
- 2022
- Full Text
- View/download PDF
7. Comparative effectiveness of phlegm-heat clearing Chinese medicine injections for AECOPD: A systematic review and network meta-analysis
- Author
-
Chen, Xueyin, Kang, Fuqin, Lai, Jiaqi, Deng, Xueyi, Guo, Xinfeng, and Liu, Shaonan
- Published
- 2022
- Full Text
- View/download PDF
8. Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions.
- Author
-
Oh, Byeongsang, Yeung, Albert, Klein, Penelope, Larkey, Linda, Ee, Carolyn, Zaslawski, Chris, Knobf, Tish, Payne, Peter, Stener-Victorin, Elisabet, Lee, Richard, Choi, Whanseok, Chun, Mison, Bonucci, Massimo, Lang, Hanne-Doris, Pavlakis, Nick, Boyle, Fran, Clarke, Stephen, Back, Michael, Yang, Peiying, Wei, Yulong, Guo, Xinfeng, Weng, Chi-Hsiu D, Irwin, Michael R, Elfiky, Aymen A, and Rosenthal, David
- Subjects
Qigong ,Tai Chi ,accreditation ,certification ,guideline ,standards - Abstract
Evidence of the health and wellbeing benefits of Tai Chi and Qigong (TQ) have emerged in the past two decades, but TQ is underutilized in modern health care in Western countries due to lack of promotion and the availability of professionally qualified TQ instructors. To date, there are no government regulations for TQ instructors or for training institutions in China and Western countries, even though TQ is considered to be a part of Traditional Chinese medicine that has the potential to manage many chronic diseases. Based on an integrative health care approach, the accreditation standard guideline initiative for TQ instructors and training institutions was developed in collaboration with health professionals, integrative medicine academics, Tai Chi and Qigong master instructors and consumers including public safety officers from several countries, such as Australia, Canada, China, Germany, Italy, Korea, Sweden and USA. In this paper, the rationale for organizing the Medical Tai Chi and Qigong Association (MTQA) is discussed and the accreditation standard guideline for TQ instructors and training institutions developed by the committee members of MTQA is presented. The MTQA acknowledges that the proposed guidelines are broad, so that the diversity of TQ instructors and training institutions can be integrated with recognition that these guidelines can be developed with further refinement. Additionally, these guidelines face challenges in understanding the complexity of TQ associated with different principles, philosophies and schools of thought. Nonetheless, these guidelines represent a necessary first step as primary resource to serve and guide health care professionals and consumers, as well as the TQ community.
- Published
- 2018
9. Licorice (Glycyrrhiza spp.) and jujube (Ziziphus jujuba Mill.) formula for menopausal symptoms: Classical records, clinical evidence and experimental data
- Author
-
Coyle, Meaghan E., Liu, Jian, Yang, Hongyan, Wang, Kaiyi, Zhang, Anthony L., Guo, Xinfeng, Lu, Chuanjian, and Xue, Charlie C.
- Published
- 2021
- Full Text
- View/download PDF
10. Acupuncture combined with speech rehabilitation training for post-stroke dysarthria: a systematic review and meta-analysis of randomized controlled trials
- Author
-
Xie, Qianwen, Chen, Xueyin, Xiao, Jingmin, Liu, Shaonan, Yang, Lihong, Chen, Jing, Lai, Jiaqi, Lan, Rui, Chen, Yi, Yang, Haifang, and Guo, Xinfeng
- Published
- 2020
- Full Text
- View/download PDF
11. A Boundary Scan Test Vectors Optimization Method Based on Improved GA-AO* Approach Considering Fault Probability Model.
- Author
-
Su, Yuanzhang, Guo, Xinfeng, Luo, Hang, Wang, Jingyuan, and Liu, Zhen
- Subjects
HEURISTIC ,GENETIC algorithms ,PROBABILITY theory - Abstract
The generation of test vectors is a key technique that affects the efficiency and fault detection rate of the boundary scan test. Aiming at the local optimal solution problem of the current common test vectors generation algorithm, this paper proposes a test vectors generation algorithm based on improved GA-AO* model, through which the test vectors are generated by using the idea of heuristic search and backtracking correction. In order to speed up the heuristic search, this paper designed a heuristic function with both prior and posterior parameters to describe the influence of typical faults on the failure probability index of the test vectors. At the same time, this paper used a genetic algorithm (GA) to determine the specific values of the posterior parameters iteratively. Finally, through theoretical analysis and physical verification, compared with the test vector generated by the traditional method, the test vector generated by this method is optimized on the prior failure probability index and performs better in the physical experiment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Correlation between metabolic syndrome and hearing loss in noise-exposed workers.
- Author
-
ZHANG Chao, GUO Xinfeng, and ZHAO Shuwei
- Subjects
- *
HEARING disorders , *METABOLIC syndrome , *NOISE-induced deafness , *SATURATED fatty acids , *NOISE control , *BLOOD pressure , *SPEECH perception - Abstract
Objective To explore the correlation between metabolic syndrome (MS) and noise-induced hearing loss (NIHL) in noise-exposed workers. Methods Using the convenient sampling method, a total of 850 male noise-exposed workers in an automobile manufacturing enterprise were studied. The questionnaire survey and occupational health examination were combined to collect general demographic data, physical examination data, and other information. According to the results of high-frequency hearing loss, the noise-exposed workers were divided into the hearing loss group (326 workers) and the normal hearing group (524 workers). The single-factor analysis was used to compare the above data differences between the two groups. The binary multiple-factor logistic regression model was used to analyze the influencing factors of NIHL in noise-exposed workers. Results The non-compliance rate of noise intensity in the enterprise was 39.47% (15/38), with the highest occurrences in the welding and painting posts. The morbidity of hearing loss was 38.35% (326/850), and the MS morbidity was 27.53% (234/850). The frequency of obesity, high-level triglyceride, high-level fasting blood glucose, hypertension, MS,and the contact noise level in the hearing loss group were higher than those in the normal hearing group (P < 0.05). The results of multiple-factor logistic regression showed that, compared with the workers with a noise exposure duration ≤ 5 years, the risk of NIHL in the workers with a noise exposure duration of 11 - 15 years or > 15 years increased to 1.553 and 1.727 times, respectively (P < 0.001). Compared with the workers without MS, the risk of NIHL in the workers with MS increased to 1.863 times (P < 0.001). The risk of NIHL increases by 1.567 times for each 1 dB(A) increase in noise level (P < 0.001). Conclusions There was a correlation between MS and NIHL. In addition to emphasizing control of noise level in the workplace, attention should also be paid to adopting a low-sugar, low-salt, and low-sodium diet, reducing the intake of saturated fatty acids, and strengthening physical exercise to effectively control the blood pressure, blood sugar, and blood lipid levels of workers so as to reduce the risk of NIHL. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain
- Author
-
Guo, Xinfeng, Wiley, Clayton A., Steinman, Richard A., Sheng, Yi, Ji, Beihong, Wang, Junmei, Zhang, Liyong, Wang, Tony, Zenatai, Mazen, Billiar, Timothy R., and Wang, Qingde
- Published
- 2021
- Full Text
- View/download PDF
14. Clinical evidence of Chinese medicine therapies for depression in women during perimenopause and menopause
- Author
-
Di, Yuan Ming, Yang, Lingling, Shergis, Johannah L., Zhang, Anthony L., Li, Yan, Guo, Xinfeng, Xue, Charlie C., and Lu, Chuanjian
- Published
- 2019
- Full Text
- View/download PDF
15. First-principles study on CH3NH3PbI3 materials for perovskite solar cells
- Author
-
Wang, Shengzhao, Qiao, Jianliang, Xu, Yuan, Guo, Xinfeng, and Nan, Chunjuan
- Published
- 2018
- Full Text
- View/download PDF
16. A systematic review of acupuncture and Chinese herbal medicine for postpartum depression
- Author
-
Yang, Lingling, Di, Yuan M., Shergis, Johannah L., Li, Yan, Zhang, Anthony L., Lu, Chuanjian, Guo, Xinfeng, and Xue, Charlie C.
- Published
- 2018
- Full Text
- View/download PDF
17. Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis
- Author
-
Liu, Shaonan, Chen, Jing, Zuo, Jinhong, Lai, Jiaqi, Wu, Lei, and Guo, Xinfeng
- Published
- 2019
- Full Text
- View/download PDF
18. Orally administered Chinese herbal therapy to assist post-surgical recovery for chronic rhinosinusitis—A systematic review and meta-analysis.
- Author
-
Cui, Jing, Lin, Wenmin, May, Brian H., Luo, Qiulan, Worsnop, Christopher, Zhang, Anthony Lin, Guo, Xinfeng, Lu, Chuanjian, Li, Yunying, and Xue, Charlie C.
- Subjects
SINUSITIS ,CLINICAL trial registries ,MUCOCILIARY system ,RANDOMIZED controlled trials ,VISUAL analog scale - Abstract
This systematic review and meta-analysis aims to: assess the effectiveness and safety of orally administered Chinese herbal medicines (CHMs) as adjuncts to the post-surgical management of chronic rhinosinusitis (CRS); inform clinicians of the current evidence; identify the best available evidence; and suggest directions for further research. Randomised controlled trials (RCTs) were identified from searches of nine databases plus clinical trial registries. Participants were adults and/or children diagnosed with sinusitis or rhinosinusitis, with or without nasal polyps, who had received surgery. Interventions were CHMs used orally following surgery for CRS as additions to conventional post-surgical management. Controls received conventional post-surgical management without CHMs. Studies reported results for Sino-Nasal Outcome Test (SNOT), visual analogue scales (VAS), Lund-Mackay computed tomography score (LM), Lund-Kennedy endoscopic score (LK), mucociliary transport time (MTT), mucociliary transport rate (MTR), mucociliary clearance (MC) or quality of life (QoL). Twenty-one RCTs were included. All used oral CHMs following functional endoscopic sinus surgery (FESS). The pooled results showed no significant difference between groups for SNOT-20 at the end of treatment (EoT) but there was a significant difference at follow up (FU) in favour of additional CHMs. The VAS for total nasal symptoms (VAS-TNS) showed greater improvements in the CHM groups at EoT and FU. Only FU data were reported for LM which showed greater improvement in the CHM groups. LK showed greater improvements at EoT and FU. The measures of mucociliary transport (MTT, MTR, and MC) each showed significantly greater improvement at EoT in the group that received additional CHMs. No study reported QoL. Adverse events were not serious, but reporting was incomplete. The meta-analyses suggested the addition of oral CHMs to conventional management following FESS may improve recovery. However, most studies were not blinded, and substantial heterogeneity was evident in some meta-analyses. Blinded studies are required to further investigate the roles of oral CHMs in post-surgical recovery. Systematic review registration number: The protocol was registered in PROSPERO (CRD42019119586). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials
- Author
-
Ni, Xiaojia, Shergis, Johannah Linda, Guo, Xinfeng, Zhang, Anthony Lin, Li, Yan, Lu, Chuanjian, and Xue, Charlie Changli
- Published
- 2015
- Full Text
- View/download PDF
20. Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial
- Author
-
Wu, Yuchi, Yang, Lihong, Li, Lingli, Wu, Xiuqing, Zhong, Zhicong, He, Zhiren, Ma, Hongyan, Wang, Lixin, Lu, Zhaoyu, Cai, Cun, Zhao, Daixin, Meng, Xiangxin, Qi, Airong, Yang, Aicheng, Su, Guobin, Guo, Xinfeng, Liu, Xusheng, Zou, Chuan, and Lin, Qizhan
- Published
- 2018
- Full Text
- View/download PDF
21. Medium- and long-term efficacy of ligustrazine plus conventional medication on ischemic stroke: a systematic review and meta-analysis
- Author
-
Ni, Xiaojia, Liu, Shaonan, and Guo, Xinfeng
- Published
- 2013
- Full Text
- View/download PDF
22. A Lorentz Force EMAT Design with Racetrack Coil and Periodic Permanent Magnets for Selective Enhancement of Ultrasonic Lamb Wave Generation.
- Author
-
Guo, Xinfeng, Zhu, Wujun, Qiu, Xunlin, and Xiang, Yanxun
- Subjects
- *
ULTRASONIC waves , *LAMB waves , *LORENTZ force , *PERMANENT magnets , *ACOUSTIC transducers , *SUPERCONDUCTING magnets - Abstract
This article proposes an electromagnetic acoustic transducer (EMAT) for selectively improving the purity and amplitude of ultrasonic Lamb waves in non-ferromagnetic plates. The developed EMAT consists of a racetrack coil and a group of periodic permanent magnets (PPMs). Two-dimensional finite element simulations and experiments are implemented to analyze the working mechanism and performance of the PPM EMAT. Thanks to the specific design, the eddy currents increase with increasing wire density and the directions of the magnetic fields and Lorentz forces alternate according to the polarities of the magnet units. Wires laid uniformly beneath the magnets, and the gaps between adjacent magnets generate tangential and normal Lorentz forces, resulting in-plane (IP) and out-of-plane (OP) displacements, respectively. The constructive interference occurs when the wavelength of the generated Lamb wave is twice the spacing of the magnets, leading to large amplitudes of the targeted ultrasonic Lamb waves. Therefore, the PPM EMAT is capable of generating pure symmetric or antisymmetric mode Lamb waves at respective frequencies. The results prove that the developed PPM EMAT can generate pure either S0 or A0 mode Lamb waves at respective frequencies. The increase in wire width and wire density further increases the signal amplitudes. Compared with the case of conventional meander-line-coil (MLC) EMAT, the amplitudes of the A0 and S0 mode Lamb waves of our PPM EMAT are increased to 880% and 328%, respectively. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Chinese herbal therapy in the management of rhinosinusitis—A systematic review and meta-analysis.
- Author
-
Cui, Jing, Lin, Wenmin, May, Brian H., Luo, Qiulan, Worsnop, Christopher, Zhang, Anthony Lin, Guo, Xinfeng, Lu, Chuanjian, Li, Yunying, and Xue, Charlie C.
- Subjects
CLINICAL trial registries ,LIFE change events ,CHINESE language ,SINUSITIS ,VISUAL analog scale - Abstract
This systematic review aims to assess the effects and safety of Chinese herbal medicines (CHMs) in the management of rhinosinusitis (RS); inform clinicians of the current state of the evidence; identify the best available evidence; and suggest further directions for research. Five English and four Chinese language databases, and four clinical trial registries were searched. Eligible studies were randomised controlled trials (RCTs). Participants were diagnosed with RS based on established criteria. Test interventions were CHMs administered orally and/or nasally, excluding injections and displacement techniques. Control interventions included placebos, no additional treatment, and conventional non-invasive treatments including pharmacotherapies and/or nasal irrigation, and/or inhalations. Polyposis and post-surgical recovery were excluded. Outcomes were Sino-Nasal Outcome Test (SNOT), visual analogue scales (VAS), Lund-Mackay computed tomography score (LM), Lund-Kennedy Endoscopic score (LK), Mucociliary transport time (MTT), Mucociliary transport rate (MTR), quality of life and adverse events (AEs). Risk of bias used the Cochrane tool. Meta-analysis in Review Manager 5.4.1 used random effects for mean difference (MD) or risk ratio (RR) with 95% confidence intervals. Heterogeneity was assessed as I
2 . Thirty-four RCTs were included, 30 of chronic RS (CRS) and four of acute RS (ARS). These enrolled 3,752 participants. Five RCTs blinded participants. For CRS, comparisons with placebo showed greater improvements in the CHM groups for SNOT-20 and VAS-TNS (total nasal symptoms). Blinded comparisons with pharmacotherapies showed no differences between groups in the degree of improvement for SNOT-20, VAS-TNS, and LM, suggesting these CHMs had similar effects, at least in the short term. In ARS, pooled results found improved scores on VAS-TNS and LK suggesting a benefit for combining these CHMs with pharmacotherapies. Limitations included inadequacies in study design and methodological reporting, and insufficient reporting of AEs. Heterogeneity in some pooled results precluded strong conclusions. Further well-designed studies are needed to test whether the results are replicable. Systematic review registration number: PROSPERO (CRD42019119586). [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
24. Effects of porcine circovirus type 2 on expression of mRNA associated with endogenous antigen processing and presentation in pulmonary alveolar macrophages and circulating T lymphocytes in piglets
- Author
-
Li, Jiandong, Yu, Qi, Nie, Xiaohua, Guo, Xinfeng, Song, Qinye, and Li, Huanrong
- Published
- 2012
- Full Text
- View/download PDF
25. Dang Shen [Codonopsis pilosula (Franch.) Nannf] Herbal Formulae for Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
- Author
-
Shergis, Johannah L., Liu, Shaonan, Chen, Xiankun, Zhang, Anthony L., Guo, Xinfeng, Lu, Chuanjian, and Xue, Charlie C.
- Published
- 2015
- Full Text
- View/download PDF
26. Real-world Department of Acupuncture for Endocrine-related Obesity outpatients obesity body mass and body composition correlations based on an internet-based weight management database.
- Author
-
WANG Hanlin, CHEN Yu, GUO Xinfeng, KANG Fuqin, CHEN Jiaxin, CHEN Zhaoyue, ZHAO Shunying, YIN Lihong, WANG Ji, LI Yingshuai, LUO Jincao, CUI Haiying, LI Kangli, and XIE Changcai
- Subjects
BODY composition ,REGULATION of body weight ,DATABASE management ,BASAL metabolism ,CHINESE medicine ,OBESITY - Abstract
Objective The aim of this study was to investigate the correlations between body composition and traditional Chinese medicine (TCM) constitution in normal-weight, overweight, and obese outpatients in Department of Acupuncture for Endocrine-related Obesity. Methods The "YiJianZhong Weight Management" We Chat app was used to record patients' weight, TCM constitution (only five types of TCM constitutions were included: balanced constitution, phlegm-dampness constitution, damp-heat constitution, yang-deficiency constitution, and qi-stagnation constitution), and other information. In addition, a body composition analyzer was used to collect the information including the percentage of body fat, body mass index (BMI), basal metabolic rate, and visceral fat index. Finally, the body constitution data of patients with different TCM constitutions were summarized and analyzed. Results A total of 308 patients were included in the analysis, including 100 cases of normal-weight patients and 208 cases of obese or overweight patients. The proportions of TCM constitutions in the normal-weight patients were ranked from most to least as follows; balanced constitution > yang-deficiency constitution > damp-heat constitution > qi-stagnation constitution > phlegm-dampness constitution, while the proportions of TCM constitutions in obese and overweight patients were ranked in the same order as follows; balanced constitution > phlegm-dampness constitution > damp-heat constitution > yang-deficiency constitution > qi-stagnation constitution. There was no significant difference in the composition ratio of the different TCM constitutions between normal-weight patients and overweight, obese patients. The BMIs of all the patients were negatively correlated with the qi-stagnation constitution scores. The BMI decreased by 0.152 kg/m when the qi-stagnation constitution score increased by one point. The age and qi-stagnation constitution scores had a positive interaction with the BMI. For every 1-year increase in the average age of patients, the effect of the qi-stagnation constitution scores on the BMI changed from -0.152 kg/m to -0.147 kg/m. Conclusion In terms of the TCM constitution, a balanced constitution accounted for the highest proportion in normal-weight patients, overweight, and obese patients, while phlegm-dampness and damp-heat constitution accounted for a higher proportion in overweight and obese patients, except for the balanced constitution. In addition, in terms of the relationship between the TCM constitution and body composition, due to the negative correlation between the BMI and the qi-stagnation constitution score, overweight or obese patients with a qi-stagnation constitution should pay more attention to the influence of body composition indicators other than BMI on the development of disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Acupuncture Therapies for Individuals with Overweight or Obesity: An Overview of Systematic Reviews.
- Author
-
Chen, Jiaxin, Shergis, Johannah L, Guo, Xinfeng, Zhang, Anthony Lin, Wang, Hanlin, Lu, Chuanjian, Xue, Charlie C, and Xie, Changcai
- Subjects
ACUPUNCTURE ,BODY weight ,OBESITY ,BODY mass index ,WEIGHT loss - Abstract
Purpose: An increasing number of people are affected by overweight or obesity, and the personal and social health burden is growing rapidly. Acupuncture is gaining popularity as an alternative treatment to manage weight. This research aims to update and synthesize the evidence of acupuncture therapies from systematic reviews for treating overweight and obesity. Methods: Nine databases were searched from their inception to March 2022. Overweight or obesity was classified using standard diagnostic criteria. Published systematic reviews that included randomized controlled trials and quasi-randomized studies were eligible. Quality was assessed via the AMSTAR-2 scale and risk of bias using the ROBIS tool. Results: Thirty-eight systematic reviews were identified. Acupuncture therapies and auricular acupoint stimulation showed benefits in terms of reducing body weight and body mass index. Catgut embedding therapy and abdominal acupuncture are currently not in widespread use with insufficient evidence. Acupuncture therapies appear to be safe. Most of the reviews were assessed as having high risk of bias and low confidence in the findings. Conclusion: There is a need for larger and more methodologically sound randomized controlled trials to evaluate the effectiveness of acupuncture therapies for individuals who are affected by overweight or obesity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Differential expression of the Toll-like receptor pathway and related genes of chicken bursa after experimental infection with infectious bursa disease virus
- Author
-
Guo, Xinfeng, Wang, Liqiong, Cui, Defeng, Ruan, Wenke, Liu, Fenghua, and Li, Huanrong
- Published
- 2012
- Full Text
- View/download PDF
29. Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial.
- Author
-
He, Yihan, Zhang, Haibo, Li, Yifang, Long, Shunqin, Xiao, Shujing, May, Brian H, Lin Zhang, Anthony, Guo, Xinfeng, Xue, Charlie Changli, and Lu, Chuanjian
- Subjects
THERAPEUTIC use of narcotics ,CANCER pain ,PILOT projects ,CONFIDENCE intervals ,ACUPUNCTURE ,ANALGESICS ,PATIENT satisfaction ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,RESEARCH funding ,DESCRIPTIVE statistics ,STATISTICAL sampling ,ADVERSE health care events ,PAIN management - Abstract
Objective: Given the existing evidence for the analgesic effect of acupuncture, the current study aimed to assess whether acupuncture could be feasible and manageable as an adjunctive therapy for cancer pain in a real-world hospital setting. Methods: Thirty patients in an Oncology department with moderate or severe pain were recruited and randomized to an adjunctive acupuncture group or control group, who received pharmacotherapy for pain management without acupuncture. The duration of the treatment course was 1 week with a 2-week follow-up. In total, four acupuncture sessions were administered, on days 1/2/4/6 of the trial. Pain intensity was measured using a numerical rating scale (NRS) and the daily opioid dose was recorded. Results: The overall trends favored acupuncture for both pain intensity and daily opioid consumption. The proportion of participants experiencing at least a 2-point reduction in the NRS at the end of the treatment was 93% (n = 14/15) for the acupuncture group and 57% (n = 8/14) for the control group (risk difference (RD) 36.1%, 95% confidence interval (CI) [7.4%–65.0%]; relative risk (RR) 1.63, 95% CI [1.02–2.62]; p = 0.04). There were no serious adverse events and no dropouts during the treatment. Conclusion: This pilot study showed that adding acupuncture to routine analgesia for patients with cancer pain was feasible and acceptable to patients. The clinical effects of adding acupuncture as an adjunctive therapy need to be further evaluated. Clinical trial registration number: ChiCTR1800017023 (Chinese Clinical Trial Registry) [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study.
- Author
-
Lyu, Shaohua, Zhang, Claire Shuiqing, Zhang, Anthony Lin, Sun, Jingbo, Xue, Charlie Changli, and Guo, Xinfeng
- Subjects
CHINESE medicine ,MEDICAL protocols ,MIGRAINE ,PATIENT preferences ,HERBAL medicine ,SPREADING cortical depression - Abstract
Introduction: Migraine is a disabling, recurrent headache disorder with complex comorbidities. Conventional treatments for migraine are unsatisfactory, with side effects and limited effectiveness. Chinese herbal medicine (CHM) has been used as an alternative or complementary treatment option for migraine in China. Currently, the existing evidence of benefit of CHM for migraine has been generated from randomised clinical trials using standardised intervention with a focus on internal validity hence with limited external validity. Moreover, CHM individualised intervention design, patients' preferences and concerns, and clinicians' experience are critical to clinical decision making and therapeutic success. This real-world observational study aims to gather practice-based evidence of effects and safety of CHM for migraine in the context of integrating Chinese medicine diagnostic procedures, patients' preferences and matters relevant to clinical decision making. Methods and analysis: The study is being undertaken at the Guangdong Provincial Hospital of Chinese Medicine (GPHCM) from December 2020 to May 2022. We anticipate that approximately 400 adult migraineurs will be enrolled and observed on their migraine severity, analgesic consumption, quality of life, anxiety, depression and insomnia at baseline and then every four weeks over 12 weeks. Treatments, diagnostic information, and patient-reported most bothersome symptoms will be collected from patient clinical records. Patient's demographic data, preferences and concerns on CHM treatments will also be gathered at baseline and be analysed. Factors related to clinical outcomes will be explored with multiple correlation and multivariable regression analyses. Effects of CHM will be evaluated using generalised estimated equation, based on clinical outcome data. Discussion: This study will provide comprehensive evidence of CHM for migraine in the context of evidence-based practice. Trial registration number: ChiCTR2000041003 [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Application of the Delphi Method in the Construction of an Evaluating and Grading Scale for Evidence of Disease Prevention and Treatment in Ancient Books of Traditional Chinese Medicine.
- Author
-
Zhang, Lei, Guo, Xinfeng, Yang, Shuo, Liu, Sihong, Li, Hongtao, Chen, Guangkun, Gao, Hongjie, Zhang, Huamin, and Tong, Lin
- Subjects
- *
PREVENTIVE medicine , *CHINESE medicine , *DELPHI method - Abstract
Objective. This study aimed to develop a scale for evaluating and grading the evidence of prevention and treatment in ancient books of traditional Chinese medicine (TCM), in view of providing a reference for TCM clinicians, supporting the compilation or revision of evidence-based practice guidelines for TCM, improving the level of evidence-based research on ancient TCM books, and supplementing the development of evidence-based ancient TCM books. Methods. The Delphi method was used for consultation among 40 experts in relevant fields. Excel 2016 and SPSS 21.0 were used to analyze the positive coefficient, authority coefficient, degree of concentration, degree of coordination, and degree of expert consensus. Results. In the first round of the questionnaire, a total of 17 evaluation indexes were formulated in three aspects: 5 were deleted, 1 was modified according to the expert opinions, and no additional index was added. In addition, quantitative standards, weight assignment, and grading standards were developed according to the findings of the expert consultation. The positive coefficients of experts in the first and second rounds of questionnaires were 87.5% and 82.9%, respectively. The authority coefficient was 0.835 (>0.7). The coefficient of variation of the first and second rounds were 0.14∼0.29 and 0.09∼0.27, respectively. Kendall's coefficient of concordance of the first and second rounds were 0.135 (p < 0.05) and 0.081 (p < 0.05), respectively. Conclusion. The evaluation indexes and quantitative reference values of the developed scale conform to the characteristics of prevention and treatment evidence in ancient TCM books. It can provide a useful exploration tool for the evaluation and grading of evidences in TCM ancient books. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study.
- Author
-
Yang, Lihong, Chen, Xueyin, Li, Chuang, Xu, Peng, Mao, Wei, Liang, Xing, Zuo, Qi, Ma, Weizhong, Guo, Xinfeng, and Bao, Kun
- Subjects
HERBAL medicine ,CHINESE medicine ,CHRONIC kidney failure ,KIDNEY diseases ,GLOMERULAR filtration rate - Abstract
Introduction: Some encouraging findings of Chinese herbal medicine (CHM) in management of idiopathic membranous nephropathy (IMN) obtained in the setting of clinical trials are hard to validate in the daily clinical practice due to a complicated treatment scenario of CHM in practice. The primary objective of this registry is to provide a description of treatment patterns used in management of IMN and assess clinical remission in daily practice in a Chinese population sample with IMN. Methods and analysis: This is a prospective, multicenter cohort which will comprise 2000 adults with IMN regardless of urinary protein levels that will be recruited from 11 nephrology centers across China. The participants will be followed for up to at least 2 years. Primary outcome is composite remission (either complete remission or partial remission) 24 months after enrolment. The secondary outcomes are complete remission, partial remission, time to remission, no response, relapse, proteinuria, annual change of glomerular filtration rate, antibodies against PLA2R, and composite endpoint of 40% reduction of glomerular filtration rate, doubling of serum creatinine, end-stage renal disease, and death. Propensity score analysis will be used for matching and adjustment. Ethics and dissemination: This study has been approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (BF2020-094-01). Results of the study will be published in both national and international peer-reviewed journals, and presented at scientific conferences. Investigators will inform the participants as well as other IMN patients of the findings via health education. Study registration : ChiCTR2000033680 (prospectively registered). [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Integrating Chinese and western medicine for COVID‐19: A living evidence‐based guideline (version 1).
- Author
-
Ge, Long, Zhu, Hongfei, Wang, Qi, Li, Mengting, Cai, Jianxiong, Chen, Yang, Chen, Yaolong, Ding, Banghan, Fang, Bangjiang, Fei, Yutong, Feng, Jihong, Guo, Xinfeng, Jiang, Rongmeng, Jiang, Yuyong, Li, Guiwei, Li, Xiuhui, Li, Xucheng, Liang, Qun, Liu, Jian, and Liu, Jianping
- Subjects
COVID-19 ,CHINESE medicine ,COVID-19 pandemic ,DELPHI method ,EXPERT evidence ,DEATH rate - Abstract
Background: The coronavirus disease 2019 (COVID‐19) has turned into a pandemic and resulted in huge death tolls and burdens. Integrating Chinese and western medicine has played an important role in the fight against the COVID‐19 pandemic. Purpose: We aimed to develop a living evidence‐based guideline of integrating Chinese and western medicine for COVID‐19. Study design: Living evidence‐based guideline. Methods: This living guideline was developed using internationally recognized and accepted guideline standards, dynamically monitoring the release of new clinical evidence, and quickly updating the linked living systematic review, evidence summary tables, and recommendations. Modified Delphi method was used to reach consensus for all recommendations. The certainty of the evidence, resources, and other factors were fully considered, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to rate the certainty of evidence and the strength of recommendations. Results: The first version of this living guidance focuses on patients who are mild or moderate COVID‐19. A multidisciplinary guideline development panel was established. Ten clinical questions were identified based on the status of evidence and a face‐to‐face experts' consensus. Finally, nine recommendations were reached consensus, and were formulated from systematic reviews of the benefits and harms, certainty of evidence, public accessibility, policy supports, feedback on proposed recommendations from multidisciplinary experts, and consensus meetings. Conclusion: This guideline panel made nine recommendations, which covered five traditional Chinese medicine (TCM) prescription granules/decoction (MXXFJD, QFPD, XFBD, TJQW, and JWDY), three Chinese patent medicines (LHQW granules/capsule, JHQG granules, and LHQK granules), and one Chinese herbal injection (XBJ injection). Of them, two were strongly recommended (LHQW granules/capsule and QFPD decoction), and five were weakly recommended (MXXFJD decoction, XFBD decoction, JHQG granules, TJQW granules, and JWDY decoction) for the treatment of mild and moderate COVID‐19; two were weakly recommended against (XBJ injection and LHQK granules) the treatment of mild and moderate COVID‐19. The users of this living guideline are most likely to be clinicians, patients, governments, ministries, and health administrators. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. Comparative Effectiveness and Safety of Seven Qi-Tonifying Chinese Medicine Injections for AECOPD Patients: A Systematic Review and Network Meta-Analysis.
- Author
-
Deng, Xueyi, Kang, Fuqin, Chen, Xueyin, Lai, Jiaqi, Guan, Xuanchen, Guo, Xinfeng, and Liu, Shaonan
- Subjects
LUNG physiology ,DRUG efficacy ,ONLINE information services ,CINAHL database ,GASTROINTESTINAL system ,HERBAL medicine ,INJECTIONS ,META-analysis ,MEDICAL databases ,INFORMATION storage & retrieval systems ,MEDICAL information storage & retrieval systems ,COMBINATION drug therapy ,SYSTEMATIC reviews ,OBSTRUCTIVE lung diseases ,DESCRIPTIVE statistics ,MEDLINE ,DATA analysis software ,COMBINED modality therapy ,DRUG side effects ,DISEASE exacerbation ,CHINESE medicine ,PATIENT safety ,AMED (Information retrieval system) ,DRUG administration ,DRUG dosage ,EVALUATION - Abstract
Introduction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) imposes a large burden on economy and society worldwide. In addition to western medicine, multiple kinds of qi-tonifying Chinese medicine injections have been widely used in China as adjunctive treatments. Previous small-sample clinical trials have proven their efficacy in the treatment of AECOPD. However, data on comparative effectiveness and safety of qi-tonifying injections are limited. We conducted this network meta-analysis to compare the efficacy and safety of 7 commonly used qi-tonifying injections in patients with AECOPD. Methods. Literature search was conducted through electronic databases, including PubMed, the Cochrane Library, EMBASE, CINAHL, AMED, CBM, CNKI, Wanfang database, and VIP database. Randomized clinical trials (RCTs) exploring the efficacy of any of these 7 qi-tonifying injections were included. The primary outcome was lung function (FEV1 and FVC). R 4.0.0 and STATA 12.0 were adopted to perform the network meta-analysis using Bayesian statistics. Results. A total of 36 RCTs involving 2657 participants were included. The results of network meta-analyses indicated that Chuankezhi injection (CKZ) combined with routine treatment (RT) was superior to other qi-tonifying injections combined with RT in terms of FEV1 improvement (MD = 0.63, 95% CI: 0.22, 1.04). For improving FVC, Shengmai injection (SGM) combined with RT showed the greatest therapeutic effect (MD = 0.38, 95% CI: 0.13, 0.61). Moreover, SGM combined with RT revealed the best estimates for response rate (MD = 4.00, 95% CI: 1.34, 13.63). The main adverse events in this study were gastrointestinal reactions and injection site reactions. No serious adverse events were reported. Conclusion. In this network meta-analysis, SGM and CKZ were potential best adjunctive therapies in the treatment of AECOPD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Outcome assessment of stroke convalescence using multiple scales based on different dimensions
- Author
-
Lao, Yingrong, Guo, Xinfeng, Lai, Shilong, Liang, Weixiong, Wen, Zehuai, Wang, Qi, Huang, Peixin, and Huang, Yan
- Published
- 2006
36. Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences.
- Author
-
Liu, Shaonan, Lai, Jiaqi, Wu, Lei, and Guo, Xinfeng
- Subjects
OBSTRUCTIVE lung diseases ,COUGH ,PATIENT preferences ,CHINESE medicine ,TREATMENT effectiveness ,PATIENTS' attitudes - Abstract
Purpose: The patient's preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed to explore preferences and factors associated with CM among COPD patients. Patients and Methods: A pilot survey was conducted among COPD patients using a structured, pre-tested questionnaire. The perceptions of CM therapies (including herbal medicine, non-pharmacotherapies), and expected clinical outcomes were investigated based on patient preference. Factors associated with preference of treatment scenarios were estimated in order of importance. Results: Thirty patients were enrolled in the survey, including 27 males and 3 females. Two-thirds of the patients preferred integrative Chinese and Western medicine for the treatment of COPD. Chinese patent medicines and CM decoction therapy were more popular than CM injections. The preferred non-drug therapy was point application, followed by acupuncture, Tai chi, or Qigong. More than 70% of patients reported that important clinical outcomes were improvements in lung function (77%) and dyspnea, cough, and sputum symptoms (73%), followed by exercise endurance (50%). Besides clinical efficacy, costs and side effects were also important factors for treatment selection. Conclusion: This pilot study showed that Chinese patent medicine and CM decoctions were preferred options for complementary medicines to combine with routine pharmacotherapy for COPD treatment according to the patients' preferences. The improvement of dyspnea, cough symptoms, and lung function was the most desired clinical outcomes for patients. Quicker symptom relief, lower costs, and fewer side effects were key attributes for the treatment selection. Further research with a larger sample size is needed to definitively address the comprehensive conclusion. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Electrochemically Exfoliated Graphene/Manganese Dioxide Nanowire Composites as Electrode Materials for Flexible Supercapacitors.
- Author
-
Guo, Xinfeng, Yu, Xinling, Sun, Lidong, Chen, Liqing, Liu, Cui, Zhang, Shudong, Wang, Zhenyang, Chen, Lanli, and Li, Nian
- Subjects
- *
COMPOSITE materials , *MANGANESE dioxide , *NANOWIRES , *ELECTRIC capacity , *SUPERCAPACITORS , *ENERGY density , *SUPERCAPACITOR electrodes - Abstract
Flexible supercapacitors are of great significance for the development of intelligent electronic products and wearable devices. Herein, through reasonable design, self-supporting flexible film composites that can be used as supercapacitor electrodes, are synthesised by vacuum filtration. The composites are composed of electrochemically exfoliated graphene nanosheets and MnO2 nanowires, in which the graphene nanosheets mainly play the role of skeleton support, enhance conductivity, and provide electric double-layer capacitance, while the MnO2 nanowires mainly provide pseudocapacitance. Results show that the sample with 20 % MnO2 possesses the best electrochemical performance due to the mass ratio which can give full play to the pseudocapacitive properties of MnO2 and the conductivity of graphene. The maximum mass specific capacitance reaches 106.2 F g−1 at 0.5 A g−1, and the areal specific capacitance is 767.0 mF cm−2 at 1 mA cm−2. The electrode also maintains 86.7 % of the initial capacitance after 10000 cycles, indicating good cyclic stability. Furthermore, an asymmetric solid supercapacitor based on flexible thin films is assembled. The energy density is 20.7 W h kg−1, the power density is 1000 W kg−1, and the capacitance remains 84.2 % after 3000 cycles at 5.0 A g−1. These results suggest that the as-prepared self-supporting material has the potential to be used to construct flexible supercapacitors for wearable equipment. Electrochemically exfoliated graphene/manganese dioxide nanowire composites have been prepared as efficient electrode materials for flexible supercapacitors. In the composites, graphene nanosheets mainly play the role of skeleton support, enhance conductivity, and provide electric double-layer capacitance, while the MnO2 nanowires mainly provide pseudocapacitance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Further validation of the Health Scale of Traditional Chinese Medicine (HSTCM)
- Author
-
Wen Zehuai, Liang Weixiong, Guo Xinfeng, Zhou Luojing, Lai Shilong, Wu Darong, Ou Aihua, Zhang Guangqing, and Chen Keji
- Subjects
Other systems of medicine ,RZ201-999 - Abstract
Abstract Background Few health measurement scales are based on Chinese medicine theory. The Health Scale of Traditional Chinese Medicine (HSTCM) was developed to fill this gap. The aim of this study is to validate the HSTCM. Methods A convenience sample of 630 participants was recruited in 11 settings. All participants were asked to complete the HSTCM and World Health Organization Quality of Life Measure-Abbreviated Version (WHOQOL-BREF). Results Properties of the HSTCM were tested. Intra-class correlation coefficient representing the inter-interviewer reliability was 0.99 (95%CI) for the overall instrument. Spearman-Brown correlation coefficient and Cronbach's coefficient alpha were 0.81 and 0.94 respectively, indicating satisfactory internal reliability and inter-interviewer reliability. Spearman's rho correlation coefficient between the HSTCM and WHOQOL-BREFF was -0.67. A receiver operating characteristic (ROC) curve analysis was performed to test the discriminate validation. Areas under the ROC curve analysis for the HSTCM and its domains ranged 0.71–0.87 and all the lower levels of 95%CI were greater than 0.50. Conclusion The HSTCM was validated as a generic health scale and may complement existing health measurement scales in Chinese medicine health care.
- Published
- 2009
- Full Text
- View/download PDF
39. Oral Chinese Herbal Medicine as Prophylactic Treatment for Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Author
-
Lyu, Shaohua, Zhang, Claire Shuiqing, Guo, Xinfeng, Zhang, Anthony Lin, Sun, Jingbo, Lu, Chuanjian, Xue, Charlie Changli, and Luo, Xiaodong
- Subjects
MIGRAINE prevention ,COMPARATIVE studies ,CONFIDENCE intervals ,DRUG tolerance ,HERBAL medicine ,HETEROCYCLIC compounds ,CHINESE medicine ,META-analysis ,ORAL drug administration ,PATIENT safety ,SYSTEMATIC reviews ,VISUAL analog scale ,TREATMENT effectiveness ,THERAPEUTICS - Abstract
Background. The prophylactic effects of Chinese herbal medicine (CHM) for migraine were examined in numerous clinical trials. This review aimed to analyze the effectiveness and safety of CHM as prophylactic treatment of migraine compared to flunarizine. Methods. Nine databases were searched for randomized controlled trials (RCTs) that evaluated effects of CHM for episodic migraine prophylaxis compared to flunarizine, published before March 2019. Results. Thirty-five RCTs with 2,840 participants met the inclusion criteria, and 31 of them were included in meta-analyses. The overall meta-analysis indicated that, when compared to flunarizine, CHM reduced the frequency of migraine attacks at the end of treatment (EoT) (21 studies, mean difference (MD) −1.23, 95% confidence interval (CI) (−1.69, −0.76)) and at the end of follow-up (EoFU) (five studies, MD −0.96, 95% CI (−1.70, −0.21)). Subgroup analyses based on the treatment duration, follow-up duration, and the dosage of flunarizine showed that CHM was superior to or comparable with flunarizine in reducing migraine frequency. Similar results were also found for secondary outcomes such as the pain visual analogue scale, migraine duration, responder rate, and acute medication usage. In particular, the studies that used CHM containing herb pairs (Chuan Xiong plus Bai Zhi and Chuan Xiong plus Tian Ma) showed promising results. However, the certainty of this evidence was evaluated as "low" or "very low" using the Grading of Recommendations, Assessment, Development and Evaluations approach. Conclusion. CHM appeared to be comparable with flunarizine in reducing the frequency of episodic migraine attacks in adults at EoT and EoFU and well-tolerated by participants, regardless of the treatment duration, follow-up duration, and dosage of flunarizine. Due to the low certainty of the evidence, the suggested promising prophylactic outcomes require higher quality evidence from further rigorous RCTs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
40. Additional Benefit of Chinese Medicine Formulae Including Dioscoreae rhizome (Shanyao) for Diabetes Mellitus: Current State of Evidence.
- Author
-
Sun, Lu, Di, Yuan Ming, Lu, Chuanjian, Guo, Xinfeng, Tang, Xianyu, Zhang, Anthony Lin, Xue, Charlie Changli, and Fan, Guanjie
- Subjects
CHINESE medicine ,DIABETES ,HERBAL medicine ,BLOOD lipids ,BLOOD sugar - Abstract
Background: Chinese medicine has been used to treat diabetes symptoms for thousands of years. Dioscoreae rhizome or Shanyao is a Chinese medicinal herb that is routinely used in the treatment of diabetes mellitus (DM). Objective: The purpose of this study is to evaluate the evidence of the added benefits and safety of herbal formulae containing Shanyao in clinical studies and the possible mechanisms of Shanyao in the prevention and treatment of DM in experimental studies. Methods: We searched nine databases for randomized controlled trials (RCTs) that included Shanyao in the formulae in the treatment of type 2 DM. Furthermore, experimental studies on the prevention and treatment of DM by Shanyao in English- and Chinese-language databases were identified. Results: Fifty-three moderate quality RCTs with herbal formulae containing Shanyao were identified. Results from meta-analysis indicated that Shanyao alone or formulae containing Shanyao in addition to conventional treatments could benefit people with type 2 DM in lowering blood glucose, blood lipids and reducing insulin resistance. Moreover, adverse events were significantly lower in the CHM plus conventional group than those in the conventional group. Shanyao may exert the benefit through various mechanisms including inhibition of α -glucosidase and DPP-IV activity, increase of endogenous GLP-1 and immune regulating activities. Conclusion: Evidence from this review suggested that there appeared to be added clinical benefits associated with the use of Shanyao for DM, whether as a food supplement or as a CHM combined with hypoglycemic agents with a good safety profile. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese Medicine.
- Author
-
Xie, Qianwen, Deng, Xueyi, Xiao, Jingmin, Chen, Xueyin, He, Yihan, Yang, Lihong, Liu, Shaonan, Lai, Jiaqi, Cai, Yefeng, Sun, Jingbo, and Guo, Xinfeng
- Subjects
CLINICAL trials ,CONSENSUS (Social sciences) ,DELPHI method ,HERBAL medicine ,INTERVIEWING ,RESEARCH methodology ,HEALTH policy ,RESEARCH protocols ,CHINESE medicine ,HEALTH outcome assessment ,POLICY sciences ,QUALITY assurance ,QUALITY of life ,RESEARCH evaluation ,STROKE ,EVIDENCE-based medicine ,PROFESSIONAL practice ,HUMAN services programs - Abstract
Background. Ischemic stroke (IS) seriously impacts the quality of life of survivors. Chinese medicine (CM) has been developed for more than 2000 years and plays a key role in the treatment of ischemic stroke. Many Chinese medicine clinical trials have been conducted; however, the heterogeneity of outcome measurements and reporting limits implications of the findings in clinical practice and health policy development. Therefore, it is important to develop a core outcome set (COS) that should be used and reported in trials for ischemic stroke treated by Chinese medicine. This protocol describes the process of developing the IS-CM-COS. Methods and Analysis. The development of the COS will involve the following four steps: (1) A list of outcomes reported in the registered and published Chinese medicine trials of ischemic stroke will be extracted by conducting a systematic literature review. (2) An additional outcome list will be collected by semistructured interview to patients with ischemic stroke. (3) A two-round Delphi survey will be performed to prioritize and condense the outcomes. (4) In the consensus meeting, a final recommended COS will be developed. Discussion. The COS could improve the reliability and consistency of outcome reporting. We hope that this IS-CM-COS will be used in the future Chinese medicine trials for the treatment of ischemic stroke and improve research quality. Trial Registration. This study was registered with the Core Outcome Measures in Effectiveness Trials Initiative (http://www.comet-initiative.org/studies/details/1282). [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.
- Author
-
Xia, Xuan, May, Brian H., Zhang, Anthony Lin, Guo, Xinfeng, Lu, Chuanjian, Xue, Charlie C., and Huang, Qingchun
- Subjects
INFLAMMATION prevention ,BIOLOGICAL products ,HERBAL medicine ,LITERATURE ,CHINESE medicine ,REFERENCE books ,RHEUMATOID arthritis ,DATA mining ,THERAPEUTICS - Abstract
Background. Rheumatoid arthritis (RA) is an autoimmune disease characterized by multijoint swelling, pain, and destruction of the synovial joints. Treatments are available but new therapies are still required. One source of new therapies is natural products, including herbs used in traditional medicines. In China and neighbouring countries, natural products have been used throughout recorded history and are still in use for RA and its symptoms. This study used text-mining of a database of classical Chinese medical books to identify candidates for future clinical and experimental investigations of therapeutics for RA. Methods. The database Encyclopaedia of Traditional Chinese Medicine (Zhong Hua Yi Dian) includes the full texts of over 1,150 classical books. Eight traditional terms were searched. All citations were assessed for relevance to RA. Results and Conclusions. After removal of duplications, 3,174 citations were considered. After applying the exclusion and inclusion criteria, 548 citations of traditional formulas were included. These derived from 138 books written from 206 CE to 1948. These formulas included 5,018 ingredients (mean, 9 ingredients/formula) comprising 243 different natural products. When these text-mining results were compared to the 18 formulas recommended in a modern Chinese Medicine clinical practice guideline, 44% of the herbal formulas were the same. This suggests considerable continuity in the clinical application of these herbs between classical and modern Chinese medicine practice. Of the 15 herbs most frequently used as ingredients of the classical formulas, all have received research attention, and all have been reported to have anti-inflammatory effects. Two of these 15 herbs have already been developed into new anti-RA therapeutics—sinomenine from Sinomenium acutum (Thunb.) Rehd. & Wils and total glucosides of peony from Paeonia lactiflora Pall. Nevertheless, there remains considerable scope for further research. This text-mining approach was effective in identifying multiple natural product candidates for future research. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
43. Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain: A Systematic Review and Meta-Analysis.
- Author
-
He, Yihan, Guo, Xinfeng, May, Brian H., Zhang, Anthony Lin, Liu, Yihong, Lu, Chuanjian, Mao, Jun J., Xue, Charlie Changli, and Zhang, Haibo
- Published
- 2020
- Full Text
- View/download PDF
44. Managing Depression with Bupleurum chinense Herbal Formula: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Author
-
Yang, Lingling, Shergis, Johannah L., Di, Yuan M., Zhang, Anthony L., Lu, Chuanjian, Guo, Xinfeng, Fang, Zenan, Xue, Charlie Changli, and Li, Yan
- Subjects
ANTIDEPRESSANTS ,COMBINATION drug therapy ,CINAHL database ,CONFIDENCE intervals ,MENTAL depression ,HAMILTON Depression Inventory ,HERBAL medicine ,MEDICAL information storage & retrieval systems ,CHINESE medicine ,MEDLINE ,META-analysis ,ONLINE information services ,SEROTONIN uptake inhibitors ,SYSTEMATIC reviews ,AMED (Information retrieval system) ,THERAPEUTICS - Abstract
Objectives:Bupleurum chinense (BC; Radix Bupleuri) formulae are widely used in herbal medicine clinical practice for major depressive disorder (MDD). This study provides an up-to-date and comprehensive systematic review and meta-analysis of BC formula for MDD. Design: Randomized controlled trials were retrieved from English and Chinese databases, from their inceptions to March 2019. Included studies compared BC formula alone or as integrative medicine to selective serotonin reuptake inhibitor (SSRI) antidepressants. Studies included adults 18–65 years of age. People with other types of depression or physical comorbidities, such as poststroke depression, bipolar, and other mental or physical disorders, were excluded. Meta-analysis was performed using STATA software. Grading of Recommendations Assessment, Development, and Evaluation was also conducted to assess the quality of evidence. Results: Thirty studies compared BC formula to antidepressants and 25 studies compared BC formula plus antidepressants to antidepressants alone. BC formula was more effective than antidepressants at improving depression severity measured on the Hamilton Rating Scale for Depression (HRSD) (standardized mean difference [SMD] −0.35, 95% confidence interval [CI] −0.52 to −0.18, I
2 = 81.2%). Integrative use of BC formula plus SSRIs was also superior to SSRIs alone at improving HRSD scores (SMD −1.03, 95% CI −1.43 to −0.62, I2 = 94.2%). However, heterogeneity of the included studies was high and quality was low. The total number and severity of adverse events in the BC formula groups were less than that in the antidepressant groups. Conclusions: BC formula alone or given as integrative medicine with antidepressants reduced depression severity. However, the evidence is low quality and at risk of bias. Well-designed studies are needed to validate the results we identified in this review. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
45. Pueraria lobata for Diabetes Mellitus: Past, Present and Future.
- Author
-
Yang, Lihong, Chen, Jing, Lu, Huanyu, Lai, Jiaqi, He, Yihan, Liu, Shaonan, and Guo, Xinfeng
- Subjects
PHYTOTHERAPY ,ANIMAL experimentation ,CARRIER proteins ,COMBINATION drug therapy ,HERBAL medicine ,HYPOGLYCEMIC agents ,MEDICAL information storage & retrieval systems ,INSULIN resistance ,CHINESE medicine ,MEDLINE ,META-analysis ,MOLECULAR structure ,TYPE 2 diabetes ,ONLINE information services ,PATIENT safety ,RATS ,SYSTEMATIC reviews ,IN vitro studies ,IN vivo studies ,THERAPEUTICS - Abstract
Gegen (Radix Puerariae Lobatae), the root of Pueraria lobata, is an edible and medicinal herb which has been used in treating diabetic symptoms in the orient for thousands of years. We present an evidence map of the efficacy and safety of Gegen and Gegen formulas (GGFs) that use Gegen as an essential herb for diabetes, and also its mechanism of actions. We comprehensively searched the ancient medical records to identify empirical evidence; conducted a systematic review (SR) based on moderate- to high-quality randomized controlled trials (RCTs) to synthesize the clinical evidence; and reviewed the possible mechanisms of its antidiabetic effects. Empirical application of Gegen in treating diabetic symptoms dated back to more than 2000 years ago. Common herbs used in RCTs that accompany with Gegen included Radix et Rhizoma Glycyrrhizae, Radix et Rhizoma Ginseng, Rhizoma Dioscoreae, Poria, and Radix Ophiopogonis. The combinations used today are consistent with their usage in ancient times. Results of the SR showed that GGFs could benefit patients with type 2 diabetes for blood glucose control. When in combination with hypoglycemic agents or insulin, GGFs enhanced the glucose-lowering effect as well as the lipid-lowering effects. Also, the incidence and the risk of adverse events (AE), especially the hypoglycemic episodes, were lower in the combination group. No serious or life-threatening AE was reported. The experimental evidence presented that Gegen and GGFs might exert and enhance the anti-diabetic effects through activation of multiple mechanisms, such as reducing insulin resistance, increasing insulin release, inhibiting glucose absorption and reabsorption, and improving insulin sensitivity, glucose uptake, and metabolism. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
46. Unidirectional Self-Driving Liquid Droplet Transport on a Monolayer Graphene-Covered Textured Substrate.
- Author
-
Zhang, Zhongqiang, Guo, Xinfeng, Tang, Huayuan, Ding, Jianning, Zheng, Yong-Gang, and Li, Shaofan
- Published
- 2019
- Full Text
- View/download PDF
47. Add-On Effects of Chinese Herbal Medicine for Post-Stroke Spasticity: A Systematic Review and Meta-Analysis.
- Author
-
Cai, Yiyi, Zhang, Claire Shuiqing, Liu, Shaonan, Wen, Zehuai, Zhang, Anthony Lin, Guo, Xinfeng, Xue, Charlie Changli, and Lu, Chuanjian
- Subjects
HERBAL medicine ,CHINESE medicine ,META-analysis ,SPASTICITY ,THERAPEUTICS ,RANDOMIZED controlled trials - Abstract
Background: Treatment for post-stroke spasticity (PSS) remains a major challenge in clinical practice. Chinese herbal medicine (CHM) is often administered to assist in routine care (RC) in the treatment of PSS, with increasing numbers of clinical research and preclinical studies suggesting that it has potential benefits. Therefore, we conducted a systematic review and meta-analysis to evaluate the add-on effects and safety of CHM for PSS. Methods: Five English and four Chinese databases were searched from their respective inception to 28 February 2018. We included randomized controlled trials that evaluated the add-on effects of CHM for PSS, based on changes in the scores of the (Modified) Ashworth Scale (AS or MAS), Fugl-Meyer Assessment of Sensorimotor Recovery (FMA), and Barthel Index (BI). Results: Thirty-five trials involving 2,457 patients were included. For upper-limb AS or MAS, the estimated add-on effects of CHM to RC were significantly better when using oral (SMD −1.79, 95% CI: −3.00 to −0.57) or topical CHM (SMD −1.06, 95% CI: −1.40 to −0.72). For lower-limb AS or MAS, significant add-on benefits to RC were also detected (SMD −1.01, 95% CI: −1.43 to −0.59 and SMD −1.16, 95% CI: −1.83 to −0.49) using oral and topical CHM, respectively. For FMA and BI, better results were detected when adding CHM to RC, except for the subgroup of oral CHM for upper-limb FMA. Ten of the 35 included studies reported safety information, with two of them mentioning two mild adverse events. Conclusions: Noting the quality concerns of the included trials, this review suggests that CHM appears to be a well-tolerated therapy for patients with PSS, and the potential add-on effects of CHM in reducing spasticity and improving the daily activities of patients with PSS require further rigorous assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
48. Traditional Use of Chinese Herbal Medicine for Insomnia and Priorities Setting of Future Clinical Research.
- Author
-
Ni, Xiaojia, Shergis, Johannah Linda, Zhang, Anthony Lin, Guo, Xinfeng, Lu, Chuanjian, Li, Yan, and Xue, Charlie Changli
- Subjects
CLINICAL medicine research ,HERBAL medicine ,CHINESE medicine ,INSOMNIA ,PRIORITY (Philosophy) ,RESEARCH evaluation ,RESEARCH funding ,SYSTEMATIC reviews ,COMORBIDITY ,DIAGNOSIS - Abstract
Objectives: To evaluate the traditional use of Chinese herbal medicine (CHM) for insomnia in pre-contemporary times. Materials and methods: The Encyclopedia of Traditional Chinese Medicine (fifth edition) was systematically searched using seven Chinese medicine disease nomenclatures to identify insomnia citations. Citations were coded, and frequently used herbal formulae specific for insomnia were analyzed. Results: Insomnia treatments were mentioned in 940 citations, and insomnia diagnosis treated with Chinese herbal formulae was specifically described in 800 citations. The traditional use of CHM appeared to be individualized based on the cause, pathogenesis, phase, phenotype, demographics, and concurrent medical conditions of insomnia. The most common herbal formulae for insomnia included Wen dan tang, Suan zao ren tang, Ban xia shu mi tang, and Gui pi tang. The most frequently cited herb was suan zao ren (Ziziphi spinosae semen). Conclusions: A number of herbal formulae for insomnia were cited in the historical literature. The commonly cited formulae such as Wen dan tang and Suan zao ren tang are consistent with current clinical practice and are good prospects for further therapeutic development. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
49. Electrothermal Conversion Phase Change Composites: The Case of Polyethylene Glycol Infiltrated Graphene Oxide/Carbon Nanotube Networks.
- Author
-
Guo, Xinfeng, Liu, Cui, Li, Nian, Zhang, Shudong, and Wang, Zhenyang
- Published
- 2018
- Full Text
- View/download PDF
50. Acupoint application of herbal medicine combined with pharmacotherapy for stable asthma: a meta-analysis
- Author
-
Chen, Yuanbin, Zheng, Yanchan, Shergis, Johannah Linda, Wu, Lei, Zhang, Anthony Lin, Guo, Xinfeng, Lin, Lin, Xue, Charlie Changli, and Xu, Yinji
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.